Novel vaccines targeting dendritic cells by coupling allergoids to mannan

Allergen-specific immunotherapy (AIT) is the single disease-modifying treatment for allergy. Clinical trials show AIT to be safe and effective for many patients; however, it still faces problems related to efficacy, safety, long treatment duration and low patient adherence. There has been intensive...

Descripción completa

Detalles Bibliográficos
Autores principales: Benito-Villalvilla, Cristina, Soria, Irene, Subiza, José Luis, Palomares, Oscar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267119/
https://www.ncbi.nlm.nih.gov/pubmed/30546997
http://dx.doi.org/10.1007/s40629-018-0069-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267119/
https://www.ncbi.nlm.nih.gov/pubmed/30546997
http://dx.doi.org/10.1007/s40629-018-0069-8

Ejemplares similares